A recent study from the Annals of Surgical Oncology (August, 2014) analyzes data found in the GIST registry conducted by the Kinki GIST Study Group in Japan. It was determined that by identifying asymptomatic patients, the Japanese gastric cancer screening system contributed to early detection of gastric GIST and favorable treatment outcomes.
In Japan, which has a high incidence of gastric cancer, there is a protocol in place for annual mass screening, with the aim of detecting gastric cancer in its earliest stages where there is a better prognosis. These screenings have led to early detection of GIST as well. Click here to read more about the Japanese study.
The paradigm of “early detection” is also one that Bert Vogelstein, one of the world’s most highly respected cancer researchers working out of Johns Hopkins University, feels is crucial.
In a recent article in the MIT Technology Review, early detection of cancer through cutting edge technology such as liquid biopsy, may be the wave of the future, finding disease long before the patient develops symptoms.
Vogelstein advocates an approach to cancer treatment he refers to as “Plan B,” looking to reduce cancer deaths by preventative methods such as stopping smoking, wearing sunscreen and being screened early on.
For the full article, click here.